Follow this preprint
What level of neutralising antibody protects from COVID-19?
View ORCID ProfileDavid S Khoury, View ORCID ProfileDeborah Cromer, View ORCID ProfileArnold Reynaldi, View ORCID ProfileTimothy E Schlub, View ORCID ProfileAdam K Wheatley, View ORCID ProfileJennifer A Juno, View ORCID ProfileKanta Subbarao, View ORCID ProfileStephen J Kent, View ORCID ProfileJames A Triccas, View ORCID ProfileMiles P Davenport
doi: https://doi.org/10.1101/2021.03.09.21252641
Now published in Nature Medicine doi: 10.1038/s41591-021-01377-8
David S Khoury
1Kirby Institute, University of New South Wales, Sydney, Australia
Deborah Cromer
1Kirby Institute, University of New South Wales, Sydney, Australia
Arnold Reynaldi
1Kirby Institute, University of New South Wales, Sydney, Australia
Timothy E Schlub
2Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia
Adam K Wheatley
3Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
Jennifer A Juno
3Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
Kanta Subbarao
3Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
4WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
Stephen J Kent
3Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
5Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, Victoria, Australia
6Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia
James A Triccas
7School of Medical Sciences and Marie Bashir Institute, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia
Miles P Davenport
1Kirby Institute, University of New South Wales, Sydney, Australia

Data Availability
All data is freely available upon request after publication.
Posted March 11, 2021.
What level of neutralising antibody protects from COVID-19?
David S Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E Schlub, Adam K Wheatley, Jennifer A Juno, Kanta Subbarao, Stephen J Kent, James A Triccas, Miles P Davenport
medRxiv 2021.03.09.21252641; doi: https://doi.org/10.1101/2021.03.09.21252641
Now published in Nature Medicine doi: 10.1038/s41591-021-01377-8
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
54
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (412)
- Allergy and Immunology (726)
- Anesthesia (214)
- Cardiovascular Medicine (3112)
- Dermatology (263)
- Emergency Medicine (463)
- Epidemiology (13049)
- Forensic Medicine (13)
- Gastroenterology (862)
- Genetic and Genomic Medicine (4871)
- Geriatric Medicine (449)
- Health Economics (751)
- Health Informatics (3072)
- Health Policy (1109)
- Hematology (410)
- HIV/AIDS (963)
- Medical Education (453)
- Medical Ethics (120)
- Nephrology (502)
- Neurology (4639)
- Nursing (247)
- Nutrition (689)
- Oncology (2395)
- Ophthalmology (678)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (307)
- Palliative Medicine (88)
- Pathology (516)
- Pediatrics (1243)
- Primary Care Research (522)
- Public and Global Health (7205)
- Radiology and Imaging (1607)
- Respiratory Medicine (944)
- Rheumatology (461)
- Sports Medicine (403)
- Surgery (514)
- Toxicology (65)
- Transplantation (222)
- Urology (190)